Stockreport

OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS

OS Therapies Incorporated  (OSTX) 
PDF Focus of work at JLABS on tunable Antibody Drug Conjugate linker-based platform ROCKVILLE, Md.--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or [Read more]